Taiwan Semiconductor is in a unique place in the AI arms race. Companies like AMD and Nvidia don't build any computing units; ...

But their work underpins everything the production increase needs. Engineering supports production, deliveries, and the ...

Moderna could be on the verge of a breakthrough, but the biotech's MRNA cancer vaccine catalyst is overly priced in.

Eli Lilly is currently leading the GLP-1 market, but Amylyx is seeing strong results from its GLP-1 drug candidate.

Target fell out of favor with consumers, but it has started to get back on track, and investors have taken notice.

Friday's double-digit pop celebrated a quarter in which three of four brands shrank or stalled. The one that didn't is ...

Dividend ETFs won't be as exciting as tech stocks. But most of these funds invest in companies that generate consistent ...

The biggest knock on the stock, though, is valuation. CrowdStrike shares trade at a forward price-to-sales (P/S) multiple of ...

Micron is looking beyond today's AI boom. Its latest investments reveal where it sees future demand emerging, but one major ...

D-Wave is moving from experiments to live enterprise workloads, but the valuation leaves little room for error. See what ...

HealthEquity ( HQY +3.19%) stock got hit with a substantial sell-off this week even though the company delivered sales and ...

Spousal benefits max out at 50% of the amount your spouse is entitled to at full retirement age. If you delay a spousal ...